Hello Heart & ACC: Boosting Trust in 2026
Boost trust in digital health. Learn how linking to ACC and patient outcomes builds credibility, disproving the myth that case studies are just marketing.
Boost trust in digital health. Learn how linking to ACC and patient outcomes builds credibility, disproving the myth that case studies are just marketing.
Protect patients and clinical integrity. Learn 5 key steps for safe AI in healthcare by 2026, from governance to real-world monitoring.
Innovators: What FDA rules mean for your AI medical device. Learn premarket pathways, QMS, and validation to ensure 2026 market entry.
How peer-reviewed validation speeds new Alzheimer's treatments from labs like Dr. Reed's to patients. Learn how independent verification boosts credibility.
Prevent 2026 device errors. Learn pre-market validation, FDA pathways, and oversight models that catch errors before they reach patients.
FDA's 2026 AI rules mean continuous monitoring and PCCPs for MedTech. Know what TPLC and clinical validation require for your AI devices.
FDA Pathways and Peer-Review: The Bedrock of Clinical Reliability AI tools don’t just show up in the clinic. For them to be considered reliable, they…
Clinicians and investors both need to know which AI vendors actually improve medication adherence for hypertension. This gets right to the heart of what ‘value’…
The combination of artificial intelligence and behavioral science is changing cardiovascular care. The promise is for earlier detection, more precise diagnostics, sustained patient engagement, and…
Hypertension is a massive, persistent problem, and it’s a leading driver of heart disease and death. AI gets a lot of hype, but clinicians and…